Literature DB >> 32940828

HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status.

Alaa N Qrareya1, Fakhri Mahdi1, Marc J Kaufman2, Nicole M Ashpole1,3, Jason J Paris4,5.   

Abstract

Hypogonadism is a common comorbidity associated with HIV-1 that is more prevalent among infected individuals over the age of 45. The underlying mechanisms are unknown, but both combined antiretroviral therapeutics and HIV-1 proteins, such as trans-activator of transcription protein (Tat), dysregulate steroid-synthetic mechanisms including lipid storage/synthesis and mitochondrial function. Thus, Tat expression may accelerate age-related comorbidities partly by impairing endocrine function. Few studies exist of Tat-mediated behavioral deficits in aged animals and effects of endocrine status have not been investigated. Accordingly, we tested whether conditional Tat expression in aged (~ 1.5 years old), female, Tat-transgenic [Tat(+)] mice increases anxiety-like behavior, impairs cognition, and augments mechanical allodynia, when compared to age-matched controls that do not express Tat protein [Tat(-)]. We further tested whether aged mice that maintained their endocrine status (pre-estropausal) were more resilient to Tat/age-related comorbidities than peri- or post-estropausal mice. Tat and endocrine aging status exerted separate and interacting effects that influenced anxiety-like and cognitive behaviors. Peri- and post-estropausal mice exhibited greater anxiety-like behavior in the elevated plus-maze and impaired learning in the radial arm water maze compared to pre-estropausal mice. Irrespective of estropause status, Tat(+) mice demonstrated impaired learning, reduced grip strength, and mechanical allodynia compared to Tat(-) mice. Tat exposure reduced circulating estradiol in post-estropausal mice and increased the estradiol-to-testosterone ratio in pre-estropausal mice. Changes in circulating estradiol, testosterone, and progesterone correlated with grip strength. Thus, endocrine status is an important factor in age-related anxiety, cognition, neuromuscular function, and allodynia that can be accelerated by HIV-1 Tat protein.

Entities:  

Keywords:  Aging; Estropause; Gonadal hormones; HIV/AIDS; Hypogonadism; Menopause

Mesh:

Substances:

Year:  2020        PMID: 32940828      PMCID: PMC8050151          DOI: 10.1007/s11357-020-00268-z

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  107 in total

1.  Perimenopausal symptomatology among HIV-infected women at least 40 years of age.

Authors:  R A Clark; S E Cohn; C Jarek; K S Craven; C Lyons; M Jacobson; L Kamemoto
Journal:  J Acquir Immune Defic Syndr       Date:  2000-01-01       Impact factor: 3.731

2.  Burden of HIV-Related Neuropathic Pain in the United States.

Authors:  Rachael Mann; Alesia Sadosky; Caroline Schaefer; Rebecca Baik; Bruce Parsons; Edward Nieshoff; Brett R Stacey; Michael Tuchman; Srinivas Nalamachu
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-07-14

Review 3.  HIV Eradication Strategies: Implications for the Central Nervous System.

Authors:  Rebecca T Veenhuis; Janice E Clements; Lucio Gama
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

4.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

Review 5.  HIV and aging: effects on the central nervous system.

Authors:  Silvia Cañizares; Mariana Cherner; Ronald J Ellis
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

Review 6.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

7.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

8.  Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.

Authors:  Guoku Hu; Ke Liao; Lu Yang; Gurudutt Pendyala; Yeonhee Kook; Howard S Fox; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-24       Impact factor: 4.147

9.  HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?

Authors:  Ronald A Cohen; Talia R Seider; Bradford Navia
Journal:  Alzheimers Res Ther       Date:  2015-04-06       Impact factor: 6.982

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  4 in total

1.  In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain.

Authors:  Jason J Paris; Xi Chen; Joseph Anderson; Alaa N Qrareya; Fakhri Mahdi; Fei Du; Jay P McLaughlin; Marc J Kaufman
Journal:  Geroscience       Date:  2021-04-05       Impact factor: 7.713

Review 2.  Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Emaya Moss; Nicholas S Akins; Jing Li; Hoang V Le; Jason J Paris
Journal:  J Neuroendocrinol       Date:  2021-10-14       Impact factor: 3.870

3.  Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice.

Authors:  Alaa N Qrareya; Fakhri Mahdi; Marc J Kaufman; Nicole M Ashpole; Jason J Paris
Journal:  Aging (Albany NY)       Date:  2022-07-12       Impact factor: 5.955

4.  Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice.

Authors:  Michael Ohene-Nyako; Sara R Nass; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Neurosci Lett       Date:  2020-11-14       Impact factor: 3.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.